Author Archives: Site Administrator
DFB Pharmaceuticals Agrees to Settle Whistleblower Allegations
DFB Pharmaceuticals, Inc. and its subsidiary Healthpoint Ltd. based in Ft. Worth, Texas, have agreed to settle allegations that they violated the False Claims Act in connection with the prescription drug Xenaderm. According to the U.S. Department of Justice, the terms of the agreement call for the companies to pay $28 million, plus an… Read More »
Banner Year for False Claims Act Recoveries
The Department of Justice announced that it recovered $4.9 billion for cases filed under the False Claims Act during the fiscal year ending September 30, 2012. It is the largest one-year recovery in the department’s history. Since January 2009, the government has recovered $13.3 billion in settlement and judgments in civil False Claims Act… Read More »
Morton Plant Mease Agrees to Settle Whistleblower Suit For $10.1 Million
The U.S. Justice Department announced that Morton Plant Mease Health Care, Inc., and some of its affiliates (collectively “Morton Plant’), have agreed to pay $10.1 million to settle allegations that they violated the False Claims Act. According to Morton Plant’s website, it operates a group of hospitals, outpatient and surgical centers, urgent care facilities,… Read More »
South Carolina Hospice Care Provider Agrees to Settle Whistleblower Suit
The U.S. Department of Justice announced that Harmony Care Hospice, Inc. (“Harmony”), a hospice company located in South Carolina, and its CEO Daniel J. Burton, have agreed to settle a whistleblower suit for $1.28 million. According to Harmony’s website, it has four offices located in Columbia, Greenville, Hartsville, and Union, and serves patients in… Read More »
Government Intervenes in Whistleblower Suit Alleging Misuse of Funds
The Department of Justice announced that the U.S. has intervened in a qui tam action against Texas-based Fluor Hanford, Inc. and its parent corporation, Fluor Corporation (collectively “Fluor”). The complaint was initially filed in the Eastern District of Washington in 2011 by former Fluor employee Loydene Rambo under the qui tam provisions of the… Read More »
Blackstone Medical to Pay $30 Million to Settle Whistleblower Case
Blackstone Medical, Inc., a subsidiary of Curacao-based Orthofix International NV, has agreed to pay $30 million to settle allegations that it violated the False Claims Act. Blackstone, acquired by Orthofix in 2006, specializes in the design, development and marketing of spinal implant products. Former Blackstone employee Susan Hutcheson filed a whistleblower complaint under the… Read More »
Government Joins Whistleblower Suit Against Security Contractor
The United States announced that it has taken over a qui tam lawsuit against Triple Canopy, Inc. (“Triple”) based in Reston, Virginia. According to the Justice Department, the claims are related to a $10 million dollar contract awarded to Triple in 2009 for the provision of security services at Al Asad Airbase in Iraq…. Read More »
Pharmaceutical Company Settles Whistleblower Suit for $95 Million
Boehringer Ingelheim Pharmaceuticals, Inc. (“Boehringer”) based in Connecticut has agreed to pay $95 million to settle allegations that it violated the False Claims Act. Specifically, it was alleged that Boehringer unlawfully promoted the drugs Aggrenox, Atrovent, Combivent and Micardis for off-label uses and promoted the use of Combivent and Atrovent at doses that exceeded… Read More »
U.S. Intervenes in Qui Tam Action Against Houston-Based Stevedoring Company
The Justice Department announced that it has intervened in a qui tam action brought against stevedoring company Jacintoport International LLC based in Houston, Texas. A stevedore is someone who loads and unloads freight from ships. According to the complaint, in 2007, the U.S. Agency for International Development (“USAID”) and Jacintoport entered into a contract… Read More »
RxAmerica Agrees to Pay $5.25 Million to Settle False Claims Act Allegations
According to the Justice Department, RxAmerica LLC, a wholly owned subsidiary of CVS Caremark Corporation, has agreed to pay the federal government $5.25 million to resolve allegations that it violated the False Claims Act. RxAmerica provides prescription drug benefits to Medicare beneficiaries in what is commonly referred to as a Part D plan. Medicare… Read More »